The immunopathology of acute type B hepatitis

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Springer Seminars in Immunopathology

• Publication date

  1981-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF01951491PMID 7022717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Demonstration of Hepatitis B e Antigen in Hepatitis B Core Particles Obtained from the Nucleus of Hepatocytes Infected with Hepatitis B Virus

  2007cited by this paper
• The pathology of viral hepatitis in chimpanzees

  2004cited by this paper
• Progress in Liver Diseases

  1982cited by this paper
• Pathology of the Liver

  1981cited by this paper
• Transmission of the hepatitis B virus-associated delta antigen to chimpanzees.

  1980cited by this paper
• LM-Ag and LSP--two different target antigens involved in the immunopathogenesis of chronic active hepatitis?

  1979cited by this paper
• Demonstration of hepatitis B e antigen in the core of Dane particles.

  1979cited by this paper
• Demonstration of hepatitis B e antigen in hepatitis B core particles obtained from the nucleus of hepatocytes infected with hepatitis B virus.

  1979cited by this paper
• Immunologic liver injury: the role of hepatitis B viral antigens and liver membrane antigens as targets.

  1979cited by this paper
• Incidence and significance of antibodies to delta antigen in hepatitis B virus infection.

  1979cited by this paper
• Virus-induced cell surface antigens and cell-mediated immune responses

  1979cited by this paper
• Shift from free "small" hepatitis B e antigen to IgG-bound "large" form in the circulation of human beings and a chimpanzee acutely infected with hepatitis B virus.

  1979cited by this paper
• Immunopathology of hepatitis B.

  1979cited by this paper
• Immune complexes in acute and chronic liver disease.

  1978cited by this paper
• [Anti-HBc within the framework of hepatitis B virus infection: correlation to the form of inflammation and to the viral expression].

  1978cited by this paper
• T lymphocyte-mediated cytotoxicity in HBsAg-positive liver disease.

  1978cited by this paper
• Liver-specific protein: more questions than answers.

  1978cited by this paper
• Heterogeneity and significance of HBe Ag characterization of third specificity (e3)

  1978cited by this paper
• Failure of antibody to e antigen to precipitate Dane particles containing DNA polymerase activity and hepatitis B core antigen.

  1978cited by this paper
• HLA and liver disease.

  1978cited by this paper
• Membrane Alterations as Basis of Liver Injury

  1978cited by this paper
• Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection.

  1978cited by this paper
• Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen.

  1978cited by this paper
• Localisation of e-antigen in nuclei of hepatocytes in HBsAg-positive liver diseases.

  1977cited by this paper
• T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis B virus infection

  1977cited by this paper
• Advances in viral hepatitis. Report of the WHO Expert Committee on Viral Hepatitis.

  1977cited by this paper
• Extrinsic modulation of human T-lymphocyte E rosette function associated with prolonged hepatocellular injury after viral hepatitis.

  1977cited by this paper
• Immunological Aspects of the Liver and Gastrointestinal Tract.

  1977cited by this paper
• Mécanismes immunitaires dans l'hépatite B. Aspects nouveaux et conséquences pratiques

  1977cited by this paper
• Transfer factor in the attempted treatment of patients with HBsAg-positive chronic liver disease.

  1977cited by this paper
• Release of e antigen from a Dane particle-rich preparation of hepatitis B virus

  1977cited by this paper
• Immune responses to the hepatitis B surface antigen and liver-specific lipoprotein in acute type B hepatitis.

  1977cited by this paper
• Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.

  1977cited by this paper
• Evidence for phasic sequences in nuclear HBcAg formation and cell membrane-directed flow of core particles in chronic hepatitis B.

  1977cited by this paper
• The proteins of hepatitis B dane particle cores

  1977cited by this paper
• Rapid progression of chronic active type B hepatitis in a patient with hypogammaglobulinemia.

  1977cited by this paper
• Proteins of hepatitis B surface antigen

  1977cited by this paper
• Antiviral protection by virus-immune cytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled

  1977cited by this paper
• Host specificity of a serum marker for hepatitis B: evidence that "e antigen" has the properties of an immunoglobulin.

  1977cited by this paper
• Hepatitis B "e" antigen: an apparent association with lactate dehydrogenase isozyme-5.

  1977cited by this paper
• [Immune mechanisms in hepatitis B. New aspects and consequent practices].

  1977cited by this paper
• Identification of lymphocytes in percutaneous liver biopsy cores. Different T:B cell ratio in HB sAg-positive and -negative hepatitis.

  1977cited by this paper
• Immune mechanisms in hepatitis B. New aspects and consequent practices

  1977cited by this paper
• Letter: Detection of e antigen by immunofluorescence in cytoplasm of hepatocytes of HBsAg carriers.

  1976cited by this paper
• Autoimmune reaction to a liver specific membrane antigen during acute viral hepatitis.

  1976cited by this paper
• Structure and nature of hepatitis B antigen.

  1976cited by this paper
• Epidemiology and mode of transmission of viral hepatitis A and B.

  1976cited by this paper
• Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.

  1976cited by this paper
• Identification of additional antigenic sites on Dane particles and the tubular forms of hepatitis B surface antigen.

  1976cited by this paper
• Distribution patterns of hepatitis B surface antigen (HBsAg) in the liver of hepatitis patients.

  1976cited by this paper
• Sanded nuclei in hepatitis B: eosinophilic inclusions in liver cell nuclei due to excess in hepatitis B core antigen formation.

  1976cited by this paper
• DETECTION OF e ANTIGEN BY IMMUNOFLUORESCENCE IN CYTOPLASM OF HEPATOCYTES OF HBsAg CARRIERS

  1976cited by this paper
• Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis.

  1976cited by this paper
• Lymphocyte transformation test with liver-specific protein and phytohaemagglutinin in patients with liver disease.

  1976cited by this paper
• Serum inhibitory factors (SIF) in patients with acute and chronic hepatitis and their clinical significance.

  1976cited by this paper
• Studies on the Pathogenesis of Experimental Chronic Active Hepatitis in Rabbits

  1976cited by this paper
• Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein.

  1976cited by this paper
• Differential distribution of hepatitis B surface antigen and hepatitis B core antigen in the liver of hepatitis B patients.

  1976cited by this paper
• The pathology of viral hepatitis types A and B in chimpanzees. A comparison.

  1976cited by this paper
• Liver cell surface localization of hepatitis B antigen and of immunoglobulins in acute and chronic hepatitis and in liver cirrhosis.

  1976influential reference
• Immune mechanisms in liver disease

  1976cited by this paper
• Aetiological factors in immune-mediated liver disease

  1976cited by this paper
• Structure and nature of hepatitis B antigen.

  1976cited by this paper
• Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections.

  1976cited by this paper
• Lymphocyte E rosette inhibitory factor: a regulatory serum lipoprotein

  1975cited by this paper
• Cell-mediated immunity to liver in patients with alcoholic hepatitis.

  1975cited by this paper
• Antibody to hepatitis B core antigen.

  1975cited by this paper
• Immunohistochemical demonstration of hepatitis B core and surface antigens in paraffin sections.

  1975cited by this paper
• The diagnostic significance of intrahepatocellular hepatitis-B-surface-antigen (HBsAg), hepatitis-B-core-antigen (HBcAg) and IgG for the classification of inflammatory liver diseases

  1975cited by this paper
• Cell-mediated immunity in acute and chronic hepatitis.

  1975cited by this paper
• Biophysical and biochemical properties of purified preparations of hepatitis B surface antigen (HBs Ag).

  1975cited by this paper
• Immunohistochemical demonstration of hepatitis B core and surface antigens in paraffin sections.

  1975cited by this paper
• Immunological aspects of hepatitis B virus infection.

  1975influential reference
• Letter: Hairy Cells.

  1975cited by this paper
• Viral immunology and immunopathology.

  1975cited by this paper
• Clinical pathologic correlation in viral hepatitis. The effect of the virus on the liver.

  1975cited by this paper
• Immune response to hepatitis B surface antigen

  1975cited by this paper
• Lymphocyte stimulation in hepatitis B infections.

  1975cited by this paper
• Integrator enzyme hypothesis for replication of hepatitis-B virus.

  1975cited by this paper
• Organ-specificity and diagnostic value of cell-mediated immunity against a liver-specific membrane protein: Studies in hepatic and non-hepatic diseases

  1975cited by this paper
• Pattern of core and surface expression in liver tissue reflects state of specific immune response in hepatitis B.

  1975cited by this paper
• IMMUNE RESPONSE TO HEPATITIS VIRUSES

  1975cited by this paper
• Staining methods of Australia antigen in paraffin section--detection of cytoplasmic inclusion bodies.

  1974cited by this paper
• Exposure and immunity to hepatitis-B virus in a liver unit.

  1974cited by this paper
• DNA of a Human Hepatitis B Virus Candidate

  1974cited by this paper
• Dane complexes in hepatitis B antigen.

  1974cited by this paper
• Immune reactions to hepatitis B antigen in acute and chronic hepatitis.

  1974cited by this paper
• Delayed hypersensitivity in hepatitis B: clinical correlates of in vitro production of migration inhibition factor.

  1974cited by this paper
• Agammaglobulinemia associated with Australia-antigen-positive chronic active hepatitis.

  1974cited by this paper
• Viral hepatitis, type B, DNA polymerase activity and antibody to hepatitis B core antigen.

  1974cited by this paper
• Characterization of hepatitis B antigen polypeptides.

  1974cited by this paper
• Hepatitis B and serum DNA polymerase activities in chimpanzees

  1974cited by this paper
• A lymphocyte-inhibiting factor isolated from normal human liver

  1974cited by this paper
• Hepatitis B-specific DNA polymerase activity during post-transfusion hepatitis

  1974cited by this paper
• Studies on the pathogenesis of experimental chronic active hepatitis in rabbits. I. Induction of the disease and protective effect of allogeneic liver specific proteins.

  1974cited by this paper
• Immunotherapy with antibody, lymphocytes and transfer factor in chronic hepatitis B

  1974cited by this paper
• Technical study of the leucocyte migration inhibition test in agarose. Application to PPD and to hepatitis B antigen.

  1974cited by this paper
• DNA Polymerase in the Core of the Human Hepatitis B Virus Candidate

  1974cited by this paper
• Cellular Communication by Permeable Membrane Junctions

  1974cited by this paper
• Reduction in circulating T lymphocytes in alcoholic liver disease.

  1974cited by this paper

• Immunology and immunity studied with viruses.

  2007cites this paper
• Neutralizing antiviral antibody responses

  2004cites this paper
• T cells causing immunological disease

  2004cites this paper
• Induction of protective cytotoxic T cells with viral proteins

  1994cites this paper
• Soluble CD23 and interleukin-4 levels in autoimmune chronic active hepatitis and systemic lupus erythematosus.

  1994cites this paper
• T cells causing immunological disease: immunopathology or autoimmunity?

  1992cites this paper
• Virus-induced acquired immune suppression by cytotoxic T cell-mediated immunopathology.

  1992cites this paper
• Immunopathology of chronic viral hepatitis.

  1991cites this paper
• Vaccination for disease.

  1991cites this paper
• [Changes in the interferon status of patients with viral hepatitis B when genetically engineered alpha 2-interferon is used].

  1990cites this paper
• T cell receptor gene rearrangements of T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis (PBC): Oligoclonality of PBC‐derived T cell clones

  1990cites this paper
• Major histocompatibility complex-linked susceptibility or resistance to disease caused by a noncytopathic virus varies with the disease parameter evaluated

  1989cites this paper
• Liver lesions in hepatitis B viral infection.

  1988cites this paper
• Virus-triggered AIDS: a T-cell-mediated immunopathology?

  1988cites this paper
• An acquired immune suppression in mice caused by infection with lymphocytic choriomeningitis virus

  1988cites this paper
• Experimental infection of the woodchuck (Marmota monax monax) with woodchuck hepatitis virus.

  1986cites this paper
• Cytolytic T cell clones derived from liver tissue of patients with chronic hepatitis B

  1986cites this paper
• T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I- restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay?

  1986cites this paper
• Fulminant hepatic failure in an HBsAg carrier renal transplant patient following cessation of immunosuppressive therapy.

  1985cites this paper
• Liver biopsy interpretation in hepatitis. Part II: Histopathology and classification of acute and chronic viral hepatitis/differential diagnosis.

  1983cites this paper
• Involvement of the cytotoxic/suppressor T-cell subset in liver tissue injury of patients with acute and chronic liver diseases.

  1983cites this paper
• Extrahepatic manifestations of hepatitis B infection.

  1983cites this paper